Literature DB >> 19551435

Preventing and managing complications of laparoscopic gastrectomy.

E Hanisch.   

Abstract

Mesh:

Year:  2009        PMID: 19551435     DOI: 10.1007/s00464-009-0581-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  37 in total

1.  Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.

Authors:  Niki J Agnantis; Evangelos Paraskevaidis; Dimitrios Roukos
Journal:  Ann Surg Oncol       Date:  2004-11-15       Impact factor: 5.344

2.  Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?

Authors:  Evangelos Briasoulis; Michael Fatouros; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

3.  HER2 and response to paclitaxel in node-positive breast cancer.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

4.  Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-01-24       Impact factor: 5.344

5.  Genomics and challenges toward personalized breast cancer local control.

Authors:  Dimitrios H Roukos; Efstathios Lykoudis; Theodore Liakakos
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

6.  Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations.

Authors:  Dimosthenis Ziogas; Georgios Baltogiannis; Michael Fatouros; Dimitrios H Roukos
Journal:  Ann Surg       Date:  2008-04       Impact factor: 12.969

Review 7.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

8.  Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.

Authors:  D H Roukos; P Paraschou; M Lorenz
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

Review 9.  Limitations of lymph node counts as a measure of therapy.

Authors:  Scott M Gilbert; Brent K Hollenbeck
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

Review 10.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.